Fundraising Fox

Jakob Loven

Investor

Managing Partner at Nextech Invest

Zurich, Switzerland

Writes $100K – $5M checks · typically $1.5M

Experience

  1. Juvia GroupCo-Founder and Managing Partnercurrent2025 — presentEurope
  2. Nextech Invest Ltd.Managing Partner2017 — 2025Zurich, Switzerland
  3. IDRxBoard Observer2022 — 2024Boston, MA
  4. Hexagon BioBoard Member2021 — 2024San Francisco Bay Area
  5. Flare TherapeuticsBoard Member2021 — 2024Boston, MA
  6. IconOVir BioBoard Member2021 — 2024San Diego, CA
  7. Breakthrough PropertiesAdvisory Board2020 — 2024Zurich, Switzerland
  8. Arrakis TherapeuticsBoard Member2019 — 2024Greater Boston
  9. A2 Biotherapeutics, Inc.Board Member2018 — 2024Los Angeles Metropolitan Area
  10. Boundless BioBoard Member2021 — 2024San Diego, CA
  11. Vividion Therapeutics. Inc.Board Member2019 — 2021Greater San Diego Area
  12. Kronos Bio, Inc.Board Member2019 — 2021San Mateo, California
  13. Kinnate Biopharma, Inc.Board Observer2019 — 2021San Diego, California, United States
  14. ArvinasBoard Member2018 — 2020New Haven, CT
  15. Turning Point TherapeuticsBoard Observer2018 — 2019Greater San Diego Area
  16. Autolus Ltd.Board Observer2017 — 2018London, United Kingdom
  17. Relay TherapeuticsCo-Founder2016 — 2017Greater Boston Area
  18. Third Rock VenturesSenior Investment Proffesional2015 — 2017Greater Boston Area
  19. Swedish American Chamber of Commerce - New EnglandSenior Adviser, SACC Life Science Acclerator2013 — 2016Greater Boston Area
  20. Syros PharmaceuticalsCo-Founder2013 — 2015Greater Boston Area

Education

  1. Karolinska InstitutetDoctor of Philosophy (Ph.D.), Medical Sciences2005 — 2010
  2. Anglia Ruskin UniversityBachelor's degree, Biomedical Sciences1999 — 2002
  3. Sigtunaskolan Humanistiska Läroverket (SSHL)International Baccalaureate, Natural Sciences1994 — 1996

Skills & more

Cell40Cell Biology80Molecular Biology52In Vitro13Genomics36Bioinformatics22Systems Biology11Lifesciences10Drug Discovery41Biotechnology19Biomarker Discovery2Epigenomics9
+12 moreTranscriptionCancer BiologyRNA biologyDrug DevelopmentMolecular OncologyEpigeneticsBiomarkersBiochemistryPharmaceutical IndustryChromatin ImmunoprecipitationSequencingHigh Throughput Screening

Languages English · French · Spanish · Swedish

From Jakob's professional profile.

Same school

Shared employers

Colleagues at Nextech Invest

Network4

Investors connected to Jakob in public investor directories — a warm-intro map.